Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urinary Enzyme Levels Correlate with Prediabetic Plasma Glucose

By LabMedica International staff writers
Posted on 22 Jan 2013
Urinary N-acetyl-β-D-glucosaminidase (NAG) excretion is increased in patients with impaired glucose tolerance (IGT).

During the oral glucose tolerance test (OGTT) the plasma glucose, urine glucose, and insulin levels correlate strongly with urinary N-acetyl-β-d-glucosaminidase (NAG) levels in prediabetic subjects.

Scientists at the Nippon Medical School (Tokyo, Japan) performed OGTTs on 33 men and 47 women, aged 18 to79 years, who were not yet diagnosed with diabetes mellitus (DM), and in whom HbA1c levels were equal to or greater than 6.8%. More...
The study was carried out from December 2005 through August 2010.

Urinary NAG levels were measured spectrophotometrically with sodio- metacresolsulfonphthaleinyl- N-acetyl-β-D-glucosaminide as a substrate (NAG assay kit, Shionogi & Co., Osaka, Japan). Urinary glucose levels and serum creatinine (Cr) levels were measured with enzymatic assays. The serum levels of cystatin C were measured with the N Latex Cystatin C kit (Siemens Healthcare Diagnostics, Inc., Marburg, Germany) and the fully automated particle-enhanced nephelometric immunoassay.

Forty-two subjects had normal glucose tolerance (NGT), 31 had impaired glucose tolerance (IGT), and seven had DM. NAG levels were significantly higher in subjects with DM and in subjects with IGT than in subjects with NGT. Urinary NAG in the DM group was 8.53 ± 4.96 U/g UCr, which was elevated compared to the NGT group, which ranged from 5.40 ± 3.82 U/g UCr. The IGT group's range was 6.60 ± 2.88 U/g UCr, which was also significantly higher than the nondiabetic group. The NAG level was positively correlated with plasma glucose levels at 120 minutes of the OGTT and was associated with the glycemic status of prediabetic patients.

The authors concluded that that the urinary excretion of NAG with other urinary enzymes in the prediabetic state is an appropriate biomarker for screening for prediabetic renal dysfunction. Their results suggest that postprandial hyperglycemia is an independent factor that causes renal tubular damage in prediabetes patients. The study was published on November 9, 2012, in the Journal of Clinical Laboratory Analysis.

Related Links:

Nippon Medical School
Shionogi & Co.
Siemens Healthcare Diagnostics



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.